EEP.MC Euroespes S.A.

Healthcare Biotechnology Madrid Exchange
0.3400 EUR
Close of Jul 15, 2024
0.3400 0.5400
Market cap
EUR 3.95M
P/E
-
P/B
0.88x
ROE
0.0%
Dividend yield
-
Fundamental score
1.1/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is EEP.MC undervalued?

Graham number

The Graham number of Euroespes S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Euroespes S.A. fundamental analysis

6 of 22 checks passed

ROE 0/2

Low return on equity (0.0%), below 10%.

ROA 1/1

Return on assets (0.0%) is above the industry median (-1.9%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (100.3%) is above the industry median (41.0%).

Revenue Growth 0/2

Revenue shrank 4.4% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (48.1%), up to 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

EBIT is negative, against interest expense, below 5x.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.9x) is below the industry median (2.0x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Euroespes S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Euroespes S.A.

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory,…

Full company profile